Home LiteratureArticle Details
PMID: 18202106 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Automatic classification of MR scans in Alzheimer's disease.

Brain : a journal of neurology ·Vol. 131 ·No. Pt 3 ·2008-00-00 ·Pages 681-9

Klöppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR, Ashburner J, Frackowiak RS

Abstract

To be diagnostically useful, structural MRI must reliably distinguish Alzheimer's disease (AD) from normal aging in individual scans. Recent advances in statistical learning theory have led to the application of support vector machines to MRI for detection of a variety of disease states. The aims of this study were to assess how successfully support vector machines assigned individual diagnoses and to determine whether data-sets combined from multiple scanners and different centres could be used to obtain effective classification of scans. We used linear support vector machines to classify the grey matter segment of T1-weighted MR scans from pathologically proven AD patients and cognitively normal elderly individuals obtained from two centres with different scanning equipment. Because the clinical diagnosis of mild AD is difficult we also tested the ability of support vector machines to differentiate control scans from patients without post-mortem confirmation. Finally we sought to use these methods to differentiate scans between patients suffering from AD from those with frontotemporal lobar degeneration. Up to 96% of pathologically verified AD patients were correctly classified using whole brain images. Data from different centres were successfully combined achieving comparable results from the separate analyses. Importantly, data from one centre could be used to train a support vector machine to accurately differentiate AD and normal ageing scans obtained from another centre with different subjects and different scanner equipment. Patients with mild, clinically probable AD and age/sex matched controls were correctly separated in 89% of cases which is compatible with published diagnosis rates in the best clinical centres. This method correctly assigned 89% of patients with post-mortem confirmed diagnosis of either AD or frontotemporal lobar degeneration to their respective group. Our study leads to three conclusions: Firstly, support vector machines successfully separate patients with AD from healthy aging subjects. Secondly, they perform well in the differential diagnosis of two different forms of dementia. Thirdly, the method is robust and can be generalized across different centres. This suggests an important role for computer based diagnostic image analysis for clinical practice.

MeSH Terms
Aged Aged, 80 and over Aging/pathology Alzheimer Disease/diagnosis Case-Control Studies Dementia/diagnosis Diagnosis, Differential Female Humans Image Interpretation, Computer-Assisted/methods Magnetic Resonance Imaging/methods Male Middle Aged
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Klöppel Stefan
Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK. [email protected]
Stonnington Cynthia M
Chu Carlton
Draganski Bogdan
Scahill Rachael I
Rohrer Jonathan D
Fox Nick C
Jack Clifford R
Ashburner John
Frackowiak Richard S J
References (43)
43 references, click to expand
  1. Classification of structural images via high-dimensional image warping, robust feature extraction, and SVM.
    Med Image Comput Comput Assist Interv. 2005;8(Pt 1):1-8 PMID: 16685822
  2. Mapping scores onto stages: mini-mental state examination and clinical dementia rating.
    Am J Geriatr Psychiatry. 2006 Feb;14(2):139-44 PMID: 16473978
  3. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.
    Arch Neurol. 2001 Nov;58(11):1803-9 PMID: 11708987
  4. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.
    Neurology. 1998 Dec;51(6):1546-54 PMID: 9855500
  5. Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls.
    Neurobiol Aging. 2008 Jan;29(1):23-30 PMID: 17097767
  6. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
    Acta Neuropathol. 2007 Jul;114(1):5-22 PMID: 17579875
  7. A fast diffeomorphic image registration algorithm.
    Neuroimage. 2007 Oct 15;38(1):95-113 PMID: 17761438
  8. Multivariate voxel-based morphometry successfully differentiates schizophrenia patients from healthy controls.
    Neuroimage. 2007 Jan 1;34(1):235-42 PMID: 17045492
  9. Global prevalence of dementia: a Delphi consensus study.
    Lancet. 2005 Dec 17;366(9503):2112-7 PMID: 16360788
  10. Neural-network-based classification of cognitively normal, demented, Alzheimer disease and vascular dementia from single photon emission with computed tomography image data from brain.
    Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5530-4 PMID: 7777543
  11. Voxel-based morphometry to discriminate early Alzheimer's disease from controls.
    Neurosci Lett. 2005 Jul 15;382(3):269-74 PMID: 15925102
  12. Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging.
    Neurobiol Aging. 2008 Apr;29(4):514-23 PMID: 17174012
  13. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.
    Neurology. 1989 Sep;39(9):1159-65 PMID: 2771064
  14. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.
    Neurology. 1991 Apr;41(4):479-86 PMID: 2011243
  15. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Brain. 2007 Apr;130(Pt 4):1159-66 PMID: 17353226
  16. Apolipoprotein e genotype modifies the phenotype of Alzheimer disease.
    Arch Neurol. 2006 Jan;63(1):155-6 PMID: 16401755
  17. Neuropathological stageing of Alzheimer-related changes.
    Acta Neuropathol. 1991;82(4):239-59 PMID: 1759558
  18. Voxel-based morphometry--the methods.
    Neuroimage. 2000 Jun;11(6 Pt 1):805-21 PMID: 10860804
  19. Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease.
    Neuroimage. 2008 Feb 1;39(3):1180-5 PMID: 18032068
  20. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.
    Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2 PMID: 9330978
  21. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.
    Neuroimage. 2002 Sep;17(1):302-16 PMID: 12482085
  22. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.
    Neurology. 2002 May 28;58(10):1476-82 PMID: 12034782
  23. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.
    Neurology. 1992 Jan;42(1):183-8 PMID: 1734300
  24. The Alzheimer's disease neuroimaging initiative.
    Neuroimaging Clin N Am. 2005 Nov;15(4):869-77, xi-xii PMID: 16443497
  25. Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates.
    Neuroimage. 2004 Oct;23(2):574-81 PMID: 15488407
  26. Should we screen for Alzheimer's disease? A review of the evidence for and against screening Alzheimer's disease in primary care practice.
    Geriatrics. 2005 Nov;60(11):26-31 PMID: 16287338
  27. The topography of grey matter involvement in early and late onset Alzheimer's disease.
    Brain. 2007 Mar;130(Pt 3):720-30 PMID: 17293358
  28. The detection of dementia in the primary care setting.
    Arch Intern Med. 2000 Oct 23;160(19):2964-8 PMID: 11041904
  29. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Neurology. 2001 May 8;56(9):1143-53 PMID: 11342678
  30. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.
    Neuroimage. 2007 Oct 15;38(1):13-24 PMID: 17827035
  31. Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup.
    Top Magn Reson Imaging. 2005 Dec;16(6):427-37 PMID: 17088692
  32. Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects.
    Alzheimer Dis Assoc Disord. 2004 Oct-Dec;18(4):190-5 PMID: 15592129
  33. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.
    Neurology. 2002 Mar 12;58(5):750-7 PMID: 11889239
  34. Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.
    Clin Ther. 2002 Jun;24(6):862-86; discussion 837 PMID: 12117079
  35. Alzheimer's disease.
    Lancet. 2006 Jul 29;368(9533):387-403 PMID: 16876668
  36. Clinical and pathological characterization of progressive aphasia.
    Ann Neurol. 2006 Jan;59(1):156-65 PMID: 16374817
  37. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
    Neurology. 1984 Jul;34(7):939-44 PMID: 6610841
  38. Imaging cerebral atrophy: normal ageing to Alzheimer's disease.
    Lancet. 2004 Jan 31;363(9406):392-4 PMID: 15074306
  39. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease.
    Ann Neurol. 2001 Apr;49(4):433-42 PMID: 11310620
  40. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals.
    Neurology. 2002 Oct 8;59(7):1022-8 PMID: 12370456
  41. Morphological classification of brains via high-dimensional shape transformations and machine learning methods.
    Neuroimage. 2004 Jan;21(1):46-57 PMID: 14741641
  42. Classifying brain states and determining the discriminating activation patterns: Support Vector Machine on functional MRI data.
    Neuroimage. 2005 Dec;28(4):980-95 PMID: 16275139
  43. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
    Neurology. 2004 Feb 24;62(4):591-600 PMID: 14981176
Article Info
Journal
Brain : a journal of neurology
Abbr.
Brain
ISSN
1460-2156
Published
2008-00-00
Epub
2008-00-17
Pages
681-9
Language
English
Region
England
NLM ID
0372537
PMCID
PMC2579744
Subset
IM
Grants
NIA NIH HHS · P50 AG16574 · United States
NIA NIH HHS · P50 AG016574 · United States
Medical Research Council · G90/86 · United Kingdom
Wellcome Trust · 077133 · United Kingdom
NIA NIH HHS · R01 AG011378 · United States
Wellcome Trust · 075696 2/04/2 · United Kingdom
NIA NIH HHS · U01 AG06786 · United States
NIA NIH HHS · AG11378 · United States
Medical Research Council · G0601846 · United Kingdom
NIA NIH HHS · U01 AG006786 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]